Indication
Fusospirochetal pharyngitis
Fusospirochetal pharyngitis, also known as Vincent's angina or acute necrotizing ulcerative tonsillopharyngitis, is an acute polymicrobial infection involving the pharynx and palatine tonsils. Read more about Fusospirochetal pharyngitis
83 drugs 53 manufacturers
Drugs that treat it
Common Fusospirochetal pharyngitis therapies.
PENICILLIN V POTASSIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFusospirochetal pharyngitis, also known as Vincent's angina or acute necrotizing ulcerative tonsillopharyngitis, is an acute polymicrobial infection involving the pharynx and palatine tonsils.
Pathophysiologically, it is driven by an opportunistic, synergistic overgrowth of anaerobic fusiform bacilli, predominantly *Fusobacterium necrophorum* or *Fusobacterium nucleatum*, and oral spirochetes such as *Treponema* species, frequently arising in hosts with poor dentition, physical exhaustion, malnutrition, or relative immunocompromise.
Clinically, it most often presents in adolescents and adults with severe sore throat, painful swallowing, foul-smelling breath, regional cervical lymphadenopathy, and characteristically unilateral tonsillopharyngeal ulcerations covered by a dirty-gray, necrotic pseudomembrane.
- rxlist.com
Fusospirochetal pharyngitis, also known as Vincent's angina or acute necrotizing ulcerative tonsillopharyngitis, is an acute polymicrobial infection involving the pharynx and palatine tonsils
- wikipedia.org
Fusospirochetal pharyngitis, also known as Vincent's angina or acute necrotizing ulcerative tonsillopharyngitis, is an acute polymicrobial infection involving the pharynx and palatine tonsils Pathophysiologically, it is driven by an opportunistic, synergistic overgrowth of anaerobic fusiform bacilli, predominantly *Fusobacterium necrophorum* or *Fusobacterium nucleatum*, and oral spirochetes such as *Treponema* species, frequently arising in hosts with poor dentition, physical exhaustion, malnut...
- nih.gov
Pathophysiologically, it is driven by an opportunistic, synergistic overgrowth of anaerobic fusiform bacilli, predominantly *Fusobacterium necrophorum* or *Fusobacterium nucleatum*, and oral spirochetes such as *Treponema* species, frequently arising in hosts with poor dentition, physical exhaustion, malnutrition, or relative immunocompromise Clinically, it most often presents in adolescents and adults with severe sore throat, painful swallowing, foul-smelling breath, regional cervical lymphaden...
- jetem.org
Pathophysiologically, it is driven by an opportunistic, synergistic overgrowth of anaerobic fusiform bacilli, predominantly *Fusobacterium necrophorum* or *Fusobacterium nucleatum*, and oral spirochetes such as *Treponema* species, frequently arising in hosts with poor dentition, physical exhaustion, malnutrition, or relative immunocompromise
- nih.gov
Clinically, it most often presents in adolescents and adults with severe sore throat, painful swallowing, foul-smelling breath, regional cervical lymphadenopathy, and characteristically unilateral tonsillopharyngeal ulcerations covered by a dirty-gray, necrotic pseudomembrane
- hopkinsmedicine.org
Clinically, it most often presents in adolescents and adults with severe sore throat, painful swallowing, foul-smelling breath, regional cervical lymphadenopathy, and characteristically unilateral tonsillopharyngeal ulcerations covered by a dirty-gray, necrotic pseudomembrane
- voka.io
Clinically, it most often presents in adolescents and adults with severe sore throat, painful swallowing, foul-smelling breath, regional cervical lymphadenopathy, and characteristically unilateral tonsillopharyngeal ulcerations covered by a dirty-gray, necrotic pseudomembrane
Personalize your experience
Follow Fusospirochetal pharyngitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.